FDA Demands St. Jude Take Action on Medical Device Security
The FDA sent Abbott Laboratories a warning letter citing that it had inadequately addressed the security of the maligned Merlin@home Transmitter.
The FDA sent Abbott Laboratories a warning letter citing that it had inadequately addressed the security of the maligned Merlin@home Transmitter.
Comments are closed here.